Biological Psychiatry is a premier journal dedicated to advancing the understanding of the biological underpinnings of psychiatric disorders. Published by Elsevier Science Inc, this esteemed journal is recognized globally for its rigorous peer-reviewed research and contributes significantly to the field of biological psychiatry. With an impressive impact factor that places it in Q1 of its category and ranks 3rd out of 51 in Neuroscience Biological Psychiatry, it reflects the journal's strength in disseminating high-quality findings that push the boundaries of knowledge. Since its inception in 1969, the journal has undergone continuous evolution, aiming to integrate biological and clinical perspectives to optimize the understanding of mental health conditions. Although it does not offer open access, Biological Psychiatry serves as a critical resource for researchers, practitioners, and students, offering insights that influence both theoretical frameworks and practical applications in the realm of psychiatric science.

JOURNAL OF PSYCHOSOMATIC RESEARCH, published by Pergamon-Elsevier Science Ltd, stands as a premier international forum dedicated to the integration of psychological and physical health. Established in 1956, this esteemed journal has maintained a high impact in the field, currently ranking in the Q1 category for both Clinical Psychology and Psychiatry and Mental Health as of 2023. With an impressive Scopus ranking of #37/311 in Clinical Psychology and #95/567 in Psychiatry and Mental Health, it caters to a wide audience of researchers, clinicians, and students interested in the complex interplay between psychosocial factors and physical health outcomes. The journal publishes a diverse array of original research, reviews, and clinical studies, providing valuable insights into psychosomatic medicine. While it currently does not offer open access options, its robust editorial standards ensure that each publication contributes significantly to advancing the field. As the journal converges into its 68th year, it continues to be at the forefront of psychosomatic research, instrumental in shaping evidence-based practices and enhancing patient care.

BMJ Open Sport & Exercise Medicine is a leading open access journal published by the prestigious BMJ Publishing Group, dedicated to advancing the field of sports and exercise medicine. Launched in 2015, this journal has quickly made its mark, demonstrating exceptional quality as evidenced by its Q1 ranking in both Orthopedics and Sports Medicine and Physical Therapy, Sports Therapy and Rehabilitation as of 2023. With an impressive Scopus ranking, placing it in the top 8% of journals in these fields, it serves as an essential resource for researchers, practitioners, and students interested in the latest findings and innovations related to exercise and sports health. With the allure of open access, BMJ Open Sport & Exercise Medicine ensures that crucial research is readily available to a global audience, fostering collaboration and knowledge sharing across disciplines. This journal is not just a platform for publication; it is a catalyst for empirical studies and evidence-based practices that impact athletes and the rehabilitation of physical injuries.

Religion Brain & Behavior is a premier journal in the domains of Experimental and Cognitive Psychology and Religious Studies, published by Routledge Journals, Taylor & Francis Ltd. With an impressive Q1 ranking in Religious Studies and Q2 ranking in Experimental and Cognitive Psychology for 2023, this journal is recognized for its pivotal role in advancing the interdisciplinary study of the interactions between religion, brain function, and behavior. The journal's rigorous peer-review process ensures the publication of high-quality research that contributes significantly to our understanding of cognitive processes as influenced by religious belief and practice. With its notable Scopus ranking placing it in the top 2% of journals in Religious Studies, and the accessibility to a diverse range of scholarly works, Religion Brain & Behavior is an essential resource for researchers, professionals, and students seeking to explore the complexities of religion and cognition in a scholarly context. It is based in the United Kingdom, operating from its headquarters at 2-4 Park Square, Milton Park, Abingdon.

TRENDS IN NEUROSCIENCES, published by CELL PRESS, is a leading journal in the field of neuroscience, offering cutting-edge insights and important developments in the rapidly evolving landscape of brain research. With an impressive Impact Factor and ranking in the top quartile (Q1) of the category for Neuroscience (miscellaneous), it is positioned as a vital resource for researchers and professionals seeking to stay abreast of the latest discoveries and trends from 1978 to the present. Specifically ranked #3 out of 113 in General Neuroscience by Scopus, this journal promotes the interdisciplinary exchange of ideas and knowledge, making it an essential platform for students and experienced scholars alike. Although it is not an Open Access journal, its value lies in its rigorous peer-review process and commitment to maintaining the highest standards of academic integrity. By continuing to explore the complexities of neural processes and behavior, TRENDS IN NEUROSCIENCES plays a crucial role in shaping the future of neuroscience research and education.

GENES BRAIN AND BEHAVIOR is a leading journal published by Wiley that focuses on the intricate interplay between genetic factors and behavioral neuroscience. With a robust ISSN of 1601-1848 and an E-ISSN of 1601-183X, this journal serves as a premier platform for innovative research that spans across multiple fields including genetics, neurology, and behavioral neuroscience. Recognized for its significant impact with a 2023 categorization of Q1 in Behavioral Neuroscience and Q2 in both Genetics and Neurology, GENES BRAIN AND BEHAVIOR asserts itself as an influential resource for scholars, practitioners, and students alike, facilitating the advancement of knowledge in these dynamic areas. Its Scopus rankings underscore its prominence—ranking #18 in Behavioral Neuroscience and #45 in Neurology, placing it in the top percentiles among its peers. Although not an open-access journal, the rigorous peer-review process ensures high-quality publications, pivotal for those pursuing cutting-edge research and applications. With a history of convergence from 2002 to 2024, this journal continues to foster academic dialogue and discovery in the ever-evolving landscape of brain and behavioral studies.

NEUROBIOLOGY OF AGING, published by Elsevier Science Inc, is a premier journal dedicated to advancing our understanding of the complex interactions between the aging process and neurobiological mechanisms. With an ISSN of 0197-4580 and E-ISSN 1558-1497, the journal has established itself as a critical resource in the fields of Aging, Developmental Biology, Geriatrics and Gerontology, Clinical Neurology, and Neuroscience. Boasting a Q1 ranking in multiple categories, the journal is positioned within the top echelons of scholarly publication, underscoring its significant impact with an impressive Scopus ranking in various subfields. Committed to disseminating high-quality, peer-reviewed research, NEUROBIOLOGY OF AGING welcomes original articles, reviews, and research notes aiming to uncover the underlying processes of aging on the nervous system, fostering collaboration among researchers, professionals, and students alike. Although primarily subscription-based, the journal continues to play a vital role in shaping the discourse on aging and neurobiology, making it an essential publication for those engaged in this dynamic field.

Neuropsychopharmacology Reports is a leading open-access journal published by WILEY, dedicated to advancing the fields of clinical psychology, pharmacology, psychiatry, and mental health. Established in 2018, the journal aims to disseminate high-quality research findings, critical reviews, and innovative methodologies that elucidate the complexities of neuropsychopharmacology in enhancing mental health outcomes. With an impressive impact indicated by its Q2 rankings in several categories including Clinical Psychology and Pharmacology (medical) as of 2023, Neuropsychopharmacology Reports stands out as a vital resource for researchers, professionals, and students keen on exploring the interplay between pharmacological interventions and psychological well-being. The journal’s open-access nature ensures that critical advancements in this rapidly evolving field are readily available to a global audience, fostering collaboration and discourse among scholars and practitioners alike. Building on its indexed status with Scopus, the journal is positioned as a noteworthy contributor to ongoing discussions and developments in psychiatry and medical pharmacology.

Clocks & Sleep is an esteemed open access journal published by MDPI, dedicated to advancing the understanding of sleep-related phenomena through a multidisciplinary lens. Since its inception in 2019, the journal has progressively emerged as a vital resource in the fields of Neurology and Neuroscience, achieving a respectable ranking in the third quartile (Q3) among its peers according to the 2023 category quartiles. The journal's commitment to disseminating high-quality research is reflected in its Scopus rankings, placing it in the 58th percentile for Neuroscience and the 50th percentile for Neurology. Based in Switzerland, Clocks & Sleep promotes a global dialogue through its open access model, enabling researchers, professionals, and students to engage with cutting-edge findings and contribute to the growing body of literature on sleep science. With a focus on interdisciplinary studies that intersect with psychology, psychiatry, and circadian rhythms, Clocks & Sleep is poised to shape the future of sleep research.

Schizophrenia Research is a premier academic journal focused on innovative research within the domain of psychiatry and mental health, published by Elsevier. With its ISSN 0920-9964 and E-ISSN 1573-2509, the journal has established a strong presence since its inception in 1988, evolving to publish cutting-edge findings up to 2024. Positioned in Q1 in Psychiatry and Mental Health and Q2 in Biological Psychiatry, it ranks impressively in the 83rd percentile among its peers, according to Scopus, ranking #93/567 in the field of Medicine, and #12/51 in Neuroscience. This journal serves as a vital platform for the dissemination of significant scientific advancements and theoretical insights into schizophrenia, fostering a deeper understanding of mental illnesses. Although it operates on a subscription basis, its critical role in informing both ongoing research and clinical practices cannot be overstated, making it an essential resource for researchers, clinicians, and students alike. Join a global community dedicated to improving mental health outcomes and advancing the study of schizophrenia through this reputable publication.